intracerebral infusion of dopamine agonists may be a possible experimental alternative to the treatment of levodopa induced fluctuations in parkinson 's disease but stable and soluble dopamine agonists and suitable delivery systems are needed .
C0023570
levodopa
C0030567
parkinson 's disease